|
|
 |
|
Viewing report
|
|
|
|
BioNumerik Pharmaceuticals, Inc.-Therapeutic Competitors Report
Life Science Analytics, March 2011, Pages: 75
BioNumerik Pharmaceuticals, Inc.-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.
Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of clinical success for each pipeline product. Every Competitor Report compares the company against its primary competitors by individual therapeutic indication.
Scope of the reports
Competitor Reports deliver detailed analysis of a company’s preclinical, clinical and marketed pipeline of products.
A complete listing of each company’s entire pipeline is provided along with graphical and tabular presentation of the pipeline by therapeutic or disease category.
Every Competitor Report lists a company’s individual marketed and pipeline products by disease area, as well as detail on public and private company competitors for each.
An overview of each company’s discontinued product line provides insight into product attrition rates.
Competitor Reports provide extensive information including:
Company business descriptions
Product pipelines by stage of development including discontinued products
Therapeutic areas of research
Indications treated
An extensive list of competitors by disease indication.
Key benefits
Competitor Reports provide the user with independent insight into a company’s management structure, financial position and products - vital intelligence for investors, competitors and partners.
Understand the uniqueness of a company’s pipeline by obtaining detail on competitive products in development by other public and private companies - independent information that will enable the user to make informed strategic decisions.
Graphical representation of data coupled with detailed listings of all products in development and in production allows the user to quickly assess the depth of a company’s pipeline and the strength of the company’s product portfolio.
Customers who bought this item also bought
BioNumerik Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010
BioNumerik Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010
Omni Bio Pharmaceutical, Inc.-Therapeutic Competitors
BioNumerik Pharmaceuticals, Inc.-Detailed Product Pipeline
BioMarin Pharmaceutical Inc-Therapeutic Competitors
BioSante Pharmaceuticals Inc-Therapeutic Competitors
BioCryst Pharmaceuticals Inc-Therapeutic Competitors
BioPro Pharmaceutical, Inc.-Therapeutic Competitors Report
KaloBios Pharmaceuticals, Inc.-Therapeutic Competitors Report
InCode BioPharmaceutics, Inc.-Therapeutic Competitors Report
|
|
|
|
